End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.13 USD | +4.61% | +1.16% | -11.16% |
03-19 | Sipai Health Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-05 | Sipai Health Technology Expects to Narrow Loss in Full Year 2023 | MT |
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company appears highly valued given the size of its balance sheet.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-11.16% | 598M | - | ||
-31.33% | 10.96B | B | ||
+13.51% | 6.34B | C | ||
-30.66% | 6.05B | B | ||
-8.33% | 6.08B | C+ | ||
+72.00% | 5.04B | C | ||
-1.61% | 4.67B | D- | ||
-4.84% | 4B | B | ||
-16.14% | 3.28B | C- | ||
-12.02% | 2.86B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 314 Stock
- Ratings Sipai Health Technology Co., Ltd.